Literature DB >> 1269526

Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma--first evaluation.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1269526     DOI： 10.1016/0014-2964(76)90122-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  5 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

2.  Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas.

Authors:  T Trojanowski; J Peszyński; K Turowski; S Kamiński; I Gościński; M Reinfus; T Krzyszkowski; M Pyrich; A Bielawski; C Leszczyk
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

3.  Effect of HECNU in malignant supratentorial gliomas--a phase II study.

Authors:  P Georges; S Przedborski; J Brotchi; M Chatel; D Gédouin; J Hildebrand
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

4.  Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas.

Authors:  K Jellinger; P Kothbauer; D Volc; R Vollmer; R Weiss
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

5.  Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.

Authors:  P Paoletti; G Butti; R Knerich; P Gaetani; R Assietti
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.